Treatment Of Small Cell Lung Cancer: Diagnosis And Management Of Lung Cancer

Publication Date: November 1, 2013
Last Updated: March 14, 2022

Recommendations

Staging of SCLC

In patients with SCLC (proven or suspected), a staging evaluation is recommended consisting of a medical history and physical examination, CBC and comprehensive chemistry panel with renal and hepatic function tests, CT of the chest and abdomen with intravenous contrast or CT scan of the chest extending through the liver and adrenal glands, MRI or CT of the brain, and bone scan. (1, B)
307795
In patients with clinically limited-stage (LS)-SCLC, PET imaging is suggested. (2, C)
307795
In patients with SCLC, it is recommended that both the Veterans Administration system (LS vs extensive stage [ES]) and the American Joint Committee on Cancer/International Union Against Cancer seventh edition system (TNM) should be used to classify the tumor stage. (1, B)
307795

Role of Surgery

In patients with clinical stage I SCLC, who are being considered for curative intent surgical resection, invasive mediastinal staging and extrathoracic imaging (head MRI/CT and PET or abdominal CT plus bone scan) is recommended. (1, B)
307795
In patients with clinical stage I SCLC after a thorough distant and invasive mediastinal stage evaluation, surgical resection is suggested over non-surgical treatment. (2, C)
307795
In patients with stage I SCLC who have undergone curative-intent surgical resection, platinum-based adjuvant chemotherapy is recommended. (2, C)
307795

Use of RT for SCLC

In patients with LS-SCLC, early chemoradiotherapy, with accelerated hyper-fractionated radiation therapy (twice-daily treatment) concurrently with platinum-based chemotherapy, is recommended. (1, B)
307795
In patients with LS- or ES-SCLC who achieve a complete or partial response to initial therapy, PCI is recommended. (1, B)
307795
In patients with ES-SCLC who have completed chemotherapy and achieved a CR outside the chest and complete or partial response in the chest, a course of consolidative TRT is suggested. (2, C)
307795

Novel Therapies

In patients with either LS or ES-SCLC, four to six cycles of platinum-based chemotherapy with either cisplatin or carboplatin plus either etoposide or irinotecan is recommended over other chemotherapy regimens. (1, A)
307795

Second-line Treatment of SCLC

In patients with relapsed or refractory SCLC, the administration of second-line, single-agent chemotherapy is recommended. (1, B)
307795

Treatment of SCLC in the Elderly

In elderly patients with LS-SCLC and good PS (ECOG 0-2), treatment with platinum- based chemotherapy plus TRT is suggested, with close attention to management of treatmentrelated toxicity. (2, B)
307795
In elderly patients with ES-SCLC and good PS (ECOG 0-2), treatment with carboplatin-based chemotherapy is suggested. (2, A)
307795
In elderly patients with SCLC and poor PS, treatment with chemotherapy is suggested if the poor PS is due to SCLC. (2, C)
307795

Recommendation Grading

Overview

Title

Treatment Of Small Cell Lung Cancer: Diagnosis And Management Of Lung Cancer

Authoring Organization

Publication Month/Year

November 1, 2013

Last Updated Month/Year

August 24, 2023

Supplemental Implementation Tools

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

Small cell lung cancer (SCLC) is a lethal disease for which there have been only small advances in diagnosis and treatment in the past decade. Our goal was to revise the evidence-based guidelines on staging and best available treatment options.

Target Patient Population

Patients with small cell lung cancer

Inclusion Criteria

Female, Male, Adolescent, Adult, Older adult

Health Care Settings

Ambulatory, Home health, Hospice, Hospital, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Diagnosis, Management, Treatment

Diseases/Conditions (MeSH)

D013903 - Thoracic Surgery, D055752 - Small Cell Lung Carcinoma, D018288 - Carcinoma, Small Cell, D016371 - Cranial Irradiation, D060830 - Consolidation Chemotherapy

Keywords

lung cancer, management, small cell lung cancer